Literature DB >> 16944948

Focused proteomics in post-mortem human spinal cord.

Titti Ekegren1, Jörg Hanrieder, Sten-Magnus Aquilonius, Jonas Bergquist.   

Abstract

With a highly sensitive electrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry (ESI-FTICR MS) system, proteins were identified in minimal amounts of spinal cord from patients with the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and compared to proteins in spinal cord from control subjects. The results show 18 versus 16 significantly identified (p < 0.05) proteins, respectively, all known to be found in the central nervous system. The most abundant protein in both groups was the glial fibrillary acidic protein, GFAP. Other proteins were, for example, hemoglobin alpha- and beta chain, myelin basic protein, thioredoxin, alpha enolase, and choline acetyltransferase. This study also includes the technique of laser microdissection in combination with pressure catapulting (LMPC) for the dissection of samples and specific neurons. Furthermore, complementary experiments with nanoLC-matrix assisted laser desorption ionization time-of-flight tandem mass spectrometry (MALDI-TOF-TOF MS) confirmed the results of the ESI-FTICR MS screening and provided additional results of further identified proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944948     DOI: 10.1021/pr060237f

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  8 in total

1.  DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.

Authors:  Pilar Larrodé; Ana Cristina Calvo; Laura Moreno-Martínez; Miriam de la Torre; Leticia Moreno-García; Nora Molina; Tomás Castiella; Cristina Iñiguez; Luis Fernando Pascual; Francisco Javier Miana Mena; Pilar Zaragoza; Santiago Ramón Y Cajal; Rosario Osta
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

2.  The modified-bead stretched sample method: development and application to MALDI-MS imaging of protein localization in the spinal cord.

Authors:  Kevin R Tucker; Leonid A Serebryannyy; Tyler A Zimmerman; Stanislav S Rubakhin; Jonathan V Sweedler
Journal:  Chem Sci       Date:  2011       Impact factor: 9.825

Review 3.  The importance of molecular histology to study glial influence on neurodegenerative disorders. Focus on recent developed single cell laser microdissection.

Authors:  Gerson Chadi; Jessica Ruivo Maximino; Gabriela Pintar de Oliveira
Journal:  J Mol Histol       Date:  2009-11-01       Impact factor: 2.611

4.  Proteomic Analysis of Dynein-Interacting Proteins in Amyotrophic Lateral Sclerosis Synaptosomes Reveals Alterations in the RNA-Binding Protein Staufen1.

Authors:  Noga Gershoni-Emek; Arnon Mazza; Michael Chein; Tal Gradus-Pery; Xin Xiang; Ka Wan Li; Roded Sharan; Eran Perlson
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

5.  Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models.

Authors:  Mohit Raja Jain; Wei-Wen Ge; Stella Elkabes; Hong Li
Journal:  Proteomics Clin Appl       Date:  2008-05-01       Impact factor: 3.494

6.  Elevated vitreous body glial fibrillary acidic protein in retinal diseases.

Authors:  Anselm Gerhard Maria Jünemann; Robert Rejdak; Cord Huchzermeyer; Ryszard Maciejewski; Pawel Grieb; Friedrich E Kruse; Eberhart Zrenner; Konrad Rejdak; Axel Petzold
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-08-18       Impact factor: 3.117

7.  Human myocardial protein pattern reveals cardiac diseases.

Authors:  Jonas Bergquist; Gökhan Baykut; Maria Bergquist; Matthias Witt; Franz-Josef Mayer; Doan Baykut
Journal:  Int J Proteomics       Date:  2012-08-08

8.  Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS.

Authors:  Yueming Chang; Qiongman Kong; Xiu Shan; Guilian Tian; Hristelina Ilieva; Don W Cleveland; Jeffrey D Rothstein; David R Borchelt; Philip C Wong; Chien-Liang Glenn Lin
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.